Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC-Reference-Cited by-同舟云学术

Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC

Published:2014-08-15 Issue:2 Volume:10 Page:247-253
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Bosc Cecile,Ferretti Gilbert R.,Cadranel Jacques,Audigier-Valette Clarisse,Besse Benjamin,Barlesi Fabrice,Decroisette Chantal,Lantuejoul Sylvie,Arbib François,Moro-Sibilot Denis

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11523-014-0332-y.pdf

Reference31 articles.

1. Thun MJ, Hannan LM, Adams-Campbell LL et al (2008) Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 5(9):e185

2. Schiller JH, Harrington D, Belani CP et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346(2):92–98

3. Soda M, Choi YL, Enomoto M et al (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448(7153):561–566

4. Shaw AT, Yeap BY, Solomon BJ et al (2011) Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol 12(11):1004–1012

5. Camidge DR, Bang YJ, Kwak EL et al (2012) Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study. Lancet Oncol 13(10):1011–1019

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGFR;Revue des Maladies Respiratoires Actualités;2023-10

2. Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients;Cancers;2023-09-14

3. The Feasibility of Interventional Pulmonology Methods for Detecting the T790M Mutation after the First or Second-Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer;Diagnostics;2022-12-30

4. Analyse de la prise en charge des cancers bronchiques avec mutation du gène de l’EGFR;Revue des Maladies Respiratoires;2022-11

5. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGR;Revue des Maladies Respiratoires Actualités;2022-10